Results 101 to 110 of about 13,242,063 (338)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Science, 2013 Le Cong +10 more
semanticscholar +1 more source
The Teaching of Mathematics to Students of Engineering [PDF]
, 1908 Charles Skeele Palmer
openalex +1 more source
Molecular Oncology, EarlyView.Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop +10 more
wiley +1 more source
DISCUSSION. THE PROBLEM OF COAST EROSION. MARITIME AND WATERWAYS ENGINEERING DIVISION.
, 1947 F E W SHEILDS +13 more
openalex +1 more source
Molecular Oncology, EarlyView.Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed +8 more
wiley +1 more source
RNA-Guided Human Genome Engineering via Cas9
Science, 2013 P. Mali +7 more
semanticscholar +1 more source
Engineering features of the Boulder Dam-Los Angeles lines [PDF]
, 1936 E. F. Scattergood
openalex +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
Molecular Oncology, EarlyView.We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp +13 more
wiley +1 more source